The pharmaceutical sector in India showed positive movement on March 20, 2026, during early trading hours. The S&P BSE HEALTHCARE Index stood at 42,149.5, reflecting a gain of 1.1%. This compared to the benchmark S&P BSE SENSEX at 75,088.07, up 1.19%, and the NIFTY 50 (NSE) at 23,313.80, up 1.35%.
Many pharma stocks recorded gains on BSE and NSE as of approximately 9:30-9:35 AM IST. Notable performers included:
Several mid- and small-cap names also advanced, such as SMS Pharma (up 2.81-3.25%), Marksans Pharma (up 1.92-3.06%), and Sequent Scientific (up 2.05-2.15%).
The sector saw mixed performance overall, with some stocks showing minor declines or flat movement, including Ajanta Pharma (down 0.04% on BSE), Mankind Pharma (down 0.29-0.52%), and Eris Lifesciences (down 0.16% on NSE). Metropolis Healthcare recorded an anomalous drop of around 75% on both exchanges (to Rs 456.50 on BSE and Rs 454.10 on NSE), likely due to a corporate action such as a bonus issue adjustment on the record date of March 20, 2026, rather than fundamental weakness.
Top gainers in the broader pharmaceuticals space included Fervent Synergies and Vanta Bioscience (both up 8.3%), while losers featured Metropolis Healthcare and Accretion Nutraveda Ltd. (down 14.4%).
: IT sector stocks rally today, March 20: Happiest Minds surge 6.18%, Tech Mahindra humps 2.88%, Infosys up 2%
Contact to : xlf550402@gmail.com
Copyright © boyuanhulian 2020 - 2023. All Right Reserved.